News by Subject Business & Economics

More than 90 percent of human papillomavirus (HPV)-related cancers could be prevented by widespread uptake of the HPV vaccine. Yet, vaccine use in the United States falls short of public health goals.

Tumors with mutations in the BRCA2 cancer-predisposition gene respond better to checkpoint blockade immunotherapy than tumors with mutations in BRCA1, scientists at Memorial Sloan Kettering have found.

HSE University scientists have for the first time in the world investigated the impact of delayed reinforcement signals in neurofeedback (NFB) training. They have experimentally proven that reducing the delay in feedback (decreasing feedback latency) can significantly increase the efficacy of training. This opens up new potential for the use of NFB for cognitive enhancement, self-regulation, and the treatment of a broad range of neurological disorders from anxiety and depression to epilepsy.

A team of LSU Health New Orleans researchers reports for the first time that deleting one of the inhibitors of the RPE65 gene in a mouse model that carries a human disease mutation prevents degeneration of cone photoreceptors that are used for daytime high-resolution color vision.

Researchers from SMART have developed a method to produce engineered lysins that can be used to selectively kill bacteria of interest while leaving others unharmed. The discovery presents a promising alternative to antibiotics for treating existing drug-resistant bacteria without the risk of causing resistance.

New research reveals that some primary school-aged children have self-harmed, prompting calls for intervention efforts to start earlier.

We've all heard of corporate social responsibility, but what happens when companies do the opposite? This was the question of the hour at the Conference on Green and Ethical Finance, jointly organized by SMU.